Low frequency of acute hepatitis E virus (HEV) infections but high past HEV exposure in subjects from Cambodia with mild liver enzyme elevations, unexplained fever or immunodeficiency due to HIV-1 infection
•HEV infection was retrospectively assessed in 825 Cambodian subjects.•We found an overall anti-HEV IgM prevalence rate of 1.1%.•No subject tested positive for HEV RNA.•A high (30%) anti-HEV IgG prevalence rate was obtained.•Recent HEV infections were rare, contrasting with a high level of past HEV...
Saved in:
| Published in | Journal of clinical virology Vol. 71; pp. 22 - 27 |
|---|---|
| Main Authors | , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Netherlands
Elsevier B.V
01.10.2015
Elsevier |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | •HEV infection was retrospectively assessed in 825 Cambodian subjects.•We found an overall anti-HEV IgM prevalence rate of 1.1%.•No subject tested positive for HEV RNA.•A high (30%) anti-HEV IgG prevalence rate was obtained.•Recent HEV infections were rare, contrasting with a high level of past HEV exposure.
In Cambodia, previous studies conducted on hepatitis E virus (HEV) infection are scant, sometimes old, and showed inconsistent results. Moreover, there is no data about HEV infection in Cambodian HIV-1-infected patients.
To assess the occurrence of acute HEV infections and the level of past HEV exposure in one Mekong country.
Using anti-HEV IgM and HEV RNA detection, we retrospectively investigated the presence of acute HEV infection in 825 individuals, including 350 subjects with or without fever, 300 subjects with or without liver enzyme elevations (LEE) and 175 antiretroviral treatment (ART)-naïve, severely immunocompromised HIV-1-infected patients. The detection of anti-HEV IgG was also performed to assess ancient HEV exposure.
Nine individuals tested positive for anti-HEV IgM yielding an overall rate of 1.1% (95% confidence interval (CI), 0.5–2.0). We did not find significant differences for anti-HEV IgM rates between subjects with unexplained fevers (1.5%) and those with malaria or dengue-associated fever (1.7%) or non-febrile individuals (0%) (P=0.49), and between subjects with (1.5%) and without (2.0%) LEE (P=0.87). No HIV-infected patient tested positive for anti-HEV IgM. HEV RNA was not detected in all tested plasma specimens (n=578). Overall, the anti-HEV IgG prevalence rate was 30.1% (95% CI, 27.0–33.2).
The scarcity of recent HEV infection contrasted with the high level of past HEV exposure. The role of HEV in liver disease is likely minor in Cambodia since no HEV RNA was detected in our studied populations, including HIV-positive patients with severe immunodepression. |
|---|---|
| AbstractList | Highlights • HEV infection was retrospectively assessed in 825 Cambodian subjects. • We found an overall anti-HEV IgM prevalence rate of 1.1%. • No subject tested positive for HEV RNA. • A high (30%) anti-HEV IgG prevalence rate was obtained. • Recent HEV infections were rare, contrasting with a high level of past HEV exposure. Background In Cambodia, previous studies conducted on hepatitis E virus (HEV) infection are scant, sometimes old, and showed inconsistent results. Moreover, there is no data about HEV infection in Cambodian HIV-1-infected patients. Objectives To assess the occurrence of acute HEV infections and the level of past HEV exposure in one Mekong country. Study design Using anti-HEV IgM and HEV RNA detection, we retrospectively investigated the presence of acute HEV infection in 825 individuals, including 350 subjects with or without fever, 300 subjects with or without liver enzyme elevations (LEE) and 175 antiretroviral treatment (ART)-naive, severely immunocompromised HIV-1-infected patients. The detection of anti-HEV IgG was also performed to assess ancient HEV exposure. Results Nine individuals tested positive for anti-HEV IgM yielding an overall rate of 1.1% (95% confidence interval (CI), 0.5-2.0). We did not find significant differences for anti-HEV IgM rates between subjects with unexplained fevers (1.5%) and those with malaria or dengue-associated fever (1.7%) or non-febrile individuals (0%) (P =0.49), and between subjects with (1.5%) and without (2.0%) LEE (P =0.87). No HIV-infected patient tested positive for anti-HEV IgM. HEV RNA was not detected in all tested plasma specimens (n =578). Overall, the anti-HEV IgG prevalence rate was 30.1% (95% CI, 27.0-33.2). Conclusions The scarcity of recent HEV infection contrasted with the high level of past HEV exposure. The role of HEV in liver disease is likely minor in Cambodia since no HEV RNA was detected in our studied populations, including HIV-positive patients with severe immunodepression. In Cambodia, previous studies conducted on hepatitis E virus (HEV) infection are scant, sometimes old, and showed inconsistent results. Moreover, there is no data about HEV infection in Cambodian HIV-1-infected patients.BACKGROUNDIn Cambodia, previous studies conducted on hepatitis E virus (HEV) infection are scant, sometimes old, and showed inconsistent results. Moreover, there is no data about HEV infection in Cambodian HIV-1-infected patients.To assess the occurrence of acute HEV infections and the level of past HEV exposure in one Mekong country.OBJECTIVESTo assess the occurrence of acute HEV infections and the level of past HEV exposure in one Mekong country.Using anti-HEV IgM and HEV RNA detection, we retrospectively investigated the presence of acute HEV infection in 825 individuals, including 350 subjects with or without fever, 300 subjects with or without liver enzyme elevations (LEE) and 175 antiretroviral treatment (ART)-naïve, severely immunocompromised HIV-1-infected patients. The detection of anti-HEV IgG was also performed to assess ancient HEV exposure.STUDY DESIGNUsing anti-HEV IgM and HEV RNA detection, we retrospectively investigated the presence of acute HEV infection in 825 individuals, including 350 subjects with or without fever, 300 subjects with or without liver enzyme elevations (LEE) and 175 antiretroviral treatment (ART)-naïve, severely immunocompromised HIV-1-infected patients. The detection of anti-HEV IgG was also performed to assess ancient HEV exposure.Nine individuals tested positive for anti-HEV IgM yielding an overall rate of 1.1% (95% confidence interval (CI), 0.5-2.0). We did not find significant differences for anti-HEV IgM rates between subjects with unexplained fevers (1.5%) and those with malaria or dengue-associated fever (1.7%) or non-febrile individuals (0%) (P=0.49), and between subjects with (1.5%) and without (2.0%) LEE (P=0.87). No HIV-infected patient tested positive for anti-HEV IgM. HEV RNA was not detected in all tested plasma specimens (n=578). Overall, the anti-HEV IgG prevalence rate was 30.1% (95% CI, 27.0-33.2).RESULTSNine individuals tested positive for anti-HEV IgM yielding an overall rate of 1.1% (95% confidence interval (CI), 0.5-2.0). We did not find significant differences for anti-HEV IgM rates between subjects with unexplained fevers (1.5%) and those with malaria or dengue-associated fever (1.7%) or non-febrile individuals (0%) (P=0.49), and between subjects with (1.5%) and without (2.0%) LEE (P=0.87). No HIV-infected patient tested positive for anti-HEV IgM. HEV RNA was not detected in all tested plasma specimens (n=578). Overall, the anti-HEV IgG prevalence rate was 30.1% (95% CI, 27.0-33.2).The scarcity of recent HEV infection contrasted with the high level of past HEV exposure. The role of HEV in liver disease is likely minor in Cambodia since no HEV RNA was detected in our studied populations, including HIV-positive patients with severe immunodepression.CONCLUSIONSThe scarcity of recent HEV infection contrasted with the high level of past HEV exposure. The role of HEV in liver disease is likely minor in Cambodia since no HEV RNA was detected in our studied populations, including HIV-positive patients with severe immunodepression. •HEV infection was retrospectively assessed in 825 Cambodian subjects.•We found an overall anti-HEV IgM prevalence rate of 1.1%.•No subject tested positive for HEV RNA.•A high (30%) anti-HEV IgG prevalence rate was obtained.•Recent HEV infections were rare, contrasting with a high level of past HEV exposure. In Cambodia, previous studies conducted on hepatitis E virus (HEV) infection are scant, sometimes old, and showed inconsistent results. Moreover, there is no data about HEV infection in Cambodian HIV-1-infected patients. To assess the occurrence of acute HEV infections and the level of past HEV exposure in one Mekong country. Using anti-HEV IgM and HEV RNA detection, we retrospectively investigated the presence of acute HEV infection in 825 individuals, including 350 subjects with or without fever, 300 subjects with or without liver enzyme elevations (LEE) and 175 antiretroviral treatment (ART)-naïve, severely immunocompromised HIV-1-infected patients. The detection of anti-HEV IgG was also performed to assess ancient HEV exposure. Nine individuals tested positive for anti-HEV IgM yielding an overall rate of 1.1% (95% confidence interval (CI), 0.5–2.0). We did not find significant differences for anti-HEV IgM rates between subjects with unexplained fevers (1.5%) and those with malaria or dengue-associated fever (1.7%) or non-febrile individuals (0%) (P=0.49), and between subjects with (1.5%) and without (2.0%) LEE (P=0.87). No HIV-infected patient tested positive for anti-HEV IgM. HEV RNA was not detected in all tested plasma specimens (n=578). Overall, the anti-HEV IgG prevalence rate was 30.1% (95% CI, 27.0–33.2). The scarcity of recent HEV infection contrasted with the high level of past HEV exposure. The role of HEV in liver disease is likely minor in Cambodia since no HEV RNA was detected in our studied populations, including HIV-positive patients with severe immunodepression. BACKGROUND: In Cambodia, previous studies conducted on hepatitis E virus (HEV) infection are scant, sometimes old, and showed inconsistent results. Moreover, there is no data about HEV infection in Cambodian HIV-1-infected patients.OBJECTIVES: To assess the occurrence of acute HEV infections and the level of past HEV exposure in one Mekong country.STUDY DESIGN: Using anti-HEV IgM and HEV RNA detection, we retrospectively investigated the presence of acute HEV infection in 825 individuals, including 350 subjects with or without fever, 300 subjects with or without liver enzyme elevations (LEE) and 175 antiretroviral treatment (ART)-naïve, severely immunocompromised HIV-1-infected patients. The detection of anti-HEV IgG was also performed to assess ancient HEV exposure.RESULTS: Nine individuals tested positive for anti-HEV IgM yielding an overall rate of 1.1% (95% confidence interval (CI), 0.5-2.0). We did not find significant differences for anti-HEV IgM rates between subjects with unexplained fevers (1.5%) and those with malaria or dengue-associated fever (1.7%) or non-febrile individuals (0%) (P=0.49), and between subjects with (1.5%) and without (2.0%) LEE (P=0.87). No HIV-infected patient tested positive for anti-HEV IgM. HEV RNA was not detected in all tested plasma specimens (n=578). Overall, the anti-HEV IgG prevalence rate was 30.1% (95% CI, 27.0-33.2).CONCLUSIONS: The scarcity of recent HEV infection contrasted with the high level of past HEV exposure. The role of HEV in liver disease is likely minor in Cambodia since no HEV RNA was detected in our studied populations, including HIV-positive patients with severe immunodepression. In Cambodia, previous studies conducted on hepatitis E virus (HEV) infection are scant, sometimes old, and showed inconsistent results. Moreover, there is no data about HEV infection in Cambodian HIV-1-infected patients. To assess the occurrence of acute HEV infections and the level of past HEV exposure in one Mekong country. Using anti-HEV IgM and HEV RNA detection, we retrospectively investigated the presence of acute HEV infection in 825 individuals, including 350 subjects with or without fever, 300 subjects with or without liver enzyme elevations (LEE) and 175 antiretroviral treatment (ART)-naïve, severely immunocompromised HIV-1-infected patients. The detection of anti-HEV IgG was also performed to assess ancient HEV exposure. Nine individuals tested positive for anti-HEV IgM yielding an overall rate of 1.1% (95% confidence interval (CI), 0.5-2.0). We did not find significant differences for anti-HEV IgM rates between subjects with unexplained fevers (1.5%) and those with malaria or dengue-associated fever (1.7%) or non-febrile individuals (0%) (P=0.49), and between subjects with (1.5%) and without (2.0%) LEE (P=0.87). No HIV-infected patient tested positive for anti-HEV IgM. HEV RNA was not detected in all tested plasma specimens (n=578). Overall, the anti-HEV IgG prevalence rate was 30.1% (95% CI, 27.0-33.2). The scarcity of recent HEV infection contrasted with the high level of past HEV exposure. The role of HEV in liver disease is likely minor in Cambodia since no HEV RNA was detected in our studied populations, including HIV-positive patients with severe immunodepression. |
| Author | Pean, Polidy Nouhin, Janin Kim, Saorin Rouet, François Hou, Serey Vannak Barennes, Hubert Kerleguer, Alexandra Madec, Yoann Prak, Sophearot |
| Author_xml | – sequence: 1 givenname: Janin surname: Nouhin fullname: Nouhin, Janin organization: HIV/Hepatitis Unit, Pasteur Institute in Cambodia, Phnom Penh, Cambodia – sequence: 2 givenname: Hubert surname: Barennes fullname: Barennes, Hubert organization: Epidemiology and Public Health Unit, Pasteur Institute in Cambodia, Phnom Penh, Cambodia – sequence: 3 givenname: Yoann surname: Madec fullname: Madec, Yoann organization: Unité d'Epidémiologie des Maladies Emergentes, Institut Pasteur, Paris, France – sequence: 4 givenname: Sophearot surname: Prak fullname: Prak, Sophearot organization: HIV/Hepatitis Unit, Pasteur Institute in Cambodia, Phnom Penh, Cambodia – sequence: 5 givenname: Serey Vannak surname: Hou fullname: Hou, Serey Vannak organization: Medical Laboratory, Pasteur Institute in Cambodia, Phnom Penh, Cambodia – sequence: 6 givenname: Alexandra surname: Kerleguer fullname: Kerleguer, Alexandra organization: Medical Laboratory, Pasteur Institute in Cambodia, Phnom Penh, Cambodia – sequence: 7 givenname: Saorin surname: Kim fullname: Kim, Saorin organization: Malaria Unit, Pasteur Institute in Cambodia, Phnom Penh, Cambodia – sequence: 8 givenname: Polidy surname: Pean fullname: Pean, Polidy organization: Immunology Platform, Pasteur Institute in Cambodia, Phnom Penh, Cambodia – sequence: 9 givenname: François orcidid: 0000-0002-9074-8850 surname: Rouet fullname: Rouet, François email: frouet@pasteur-kh.org organization: HIV/Hepatitis Unit, Pasteur Institute in Cambodia, Phnom Penh, Cambodia |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26370310$$D View this record in MEDLINE/PubMed https://hal.science/hal-02332949$$DView record in HAL |
| BookMark | eNqNks1u1DAUhSNURH_gAdigu2wlMthxfoVUqRoNTKWRWFB1azn2NeMhiQc7SRkekmfCmSlFqkQhG0fxd06u7jmn0VFnO4yi15TMKKH5u81sI8dZQmg2I8WMkfRZdELLgsVZlRdH4Z2VeZxnLDmOTr3fkACytHgRHSc5Kwij5CT6ubJ3oB1-G7CTO7AahBx6hDVuRW9642EBo3GDh_Pl4vYCTKdR9sZ2Huqhh7X5soat8D2EW8DvW-sHh4ECP9SbQPpgbluYi7a2ygi4M_0aWtMoaMyIDrD7sWsRsMFR7G3fwtAFn0aYDhVonCDrwLTt0FmF2kizn1QNCL2F5fVtTP9M9TJ6rkXj8dX9eRbdfFjczJfx6tPH6_nVKpZZkvVxjSizTKcJ01mlUyJ1qgsmUCCrBU20lopVpFRSlwVJKFV5WpS1SgVSqZCws-jiYLsWDd860wq341YYvrxa8ekbSRhLqrQaaWDPD-zW2bBl3_PWeIlNIzq0g-e0SPOyoqwq_wOlSRGeKgnom3t0qFtUD0P8TjYA9ABIZ713qB8QSvjUHr7hoT18ag8nBQ_tCZrikUaafh9L74RpnlS-PygxLH006Ljf54TKuJAMV9Y8qb58pJaN6YwUzVfcod_YwXUhTU65Tzjhn6deT7WmGSE5yabFVX83-MfPfwFSSwnY |
| CitedBy_id | crossref_primary_10_1017_S0950268818002790 crossref_primary_10_1093_ofid_ofab178 crossref_primary_10_1111_hepr_14041 crossref_primary_10_2147_IDR_S449221 crossref_primary_10_3389_fmicb_2019_01425 crossref_primary_10_1016_j_jcv_2016_05_006 crossref_primary_10_1038_s41598_023_37941_0 crossref_primary_10_1111_trf_13731 crossref_primary_10_1002_jmv_25060 crossref_primary_10_1080_21505594_2020_1865716 crossref_primary_10_1186_s12879_024_09349_2 |
| Cites_doi | 10.1111/trf.12326 10.1016/j.jinf.2012.11.015 10.1016/j.jviromet.2012.07.027 10.1093/infdis/jit652 10.1016/j.meegid.2014.01.002 10.1371/journal.pone.0013560 10.3201/eid1810.111756 10.1086/654801 10.1016/j.jcv.2013.10.003 10.3201/eid0805.010236 10.1111/zph.12030 10.1016/j.jcv.2013.05.004 10.4269/ajtmh.2012.11-0409 10.1128/JCM.00661-13 10.1016/j.jcv.2012.09.010 10.1111/trf.12121 10.1371/journal.pone.0095868 10.3201/eid2011.140516 10.3201/eid1905.121845 10.1111/trf.12733 10.1016/j.jcv.2012.01.001 10.1016/j.jcv.2014.11.020 10.1128/CMR.00057-13 10.1128/JCM.02630-12 10.1016/S0035-9203(02)90373-1 10.1097/QAD.0000000000000378 10.1111/j.1365-2036.2007.03504.x 10.1056/NEJMoa1013911 |
| ContentType | Journal Article |
| Copyright | 2015 Elsevier B.V. Elsevier B.V. Copyright © 2015 Elsevier B.V. All rights reserved. Distributed under a Creative Commons Attribution 4.0 International License |
| Copyright_xml | – notice: 2015 Elsevier B.V. – notice: Elsevier B.V. – notice: Copyright © 2015 Elsevier B.V. All rights reserved. – notice: Distributed under a Creative Commons Attribution 4.0 International License |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7T5 7U9 C1K F1W H94 H95 H97 L.G 1XC |
| DOI | 10.1016/j.jcv.2015.07.304 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Immunology Abstracts Virology and AIDS Abstracts Environmental Sciences and Pollution Management ASFA: Aquatic Sciences and Fisheries Abstracts AIDS and Cancer Research Abstracts Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality Aquatic Science & Fisheries Abstracts (ASFA) Professional Hyper Article en Ligne (HAL) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic Aquatic Science & Fisheries Abstracts (ASFA) Professional Virology and AIDS Abstracts ASFA: Aquatic Sciences and Fisheries Abstracts AIDS and Cancer Research Abstracts Immunology Abstracts Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality Environmental Sciences and Pollution Management |
| DatabaseTitleList | Aquatic Science & Fisheries Abstracts (ASFA) Professional MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1873-5967 |
| EndPage | 27 |
| ExternalDocumentID | oai_HAL_hal_02332949v1 26370310 10_1016_j_jcv_2015_07_304 S1386653215006058 1_s2_0_S1386653215006058 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | Cambodia |
| GeographicLocations_xml | – name: Cambodia |
| GroupedDBID | --- --K --M .1- .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29K 4.4 457 4CK 4G. 53G 5GY 5VS 7-5 71M 8P~ AAAJQ AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARKO AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABFRF ABJNI ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACIUM ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADVLN AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGEKW AGHFR AGQPQ AGUBO AGYEJ AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CJTIS CS3 D-I DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA HVGLF HX~ HZ~ IHE J1W KOM LUGTX M41 MO0 N9A O-L O9- OAUVE OD- OO. OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSI SSZ T5K UNMZH Z5R ~G- AACTN AFCTW AFKWA AJOXV AMFUW RIG AAIAV ABLVK ABYKQ AJBFU EFLBG LCYCR AAYXX AGRNS CITATION CGR CUY CVF ECM EIF NPM 7X8 7T5 7U9 C1K F1W H94 H95 H97 L.G 1XC |
| ID | FETCH-LOGICAL-c525t-beec55f423f59f40cf4f73aeae3ba12ffcd3908dcf870211d6478bd4ae1cde03 |
| IEDL.DBID | .~1 |
| ISSN | 1386-6532 1873-5967 |
| IngestDate | Wed Aug 13 07:44:48 EDT 2025 Fri Jul 11 06:21:54 EDT 2025 Fri Jul 11 07:32:27 EDT 2025 Thu Apr 03 07:05:21 EDT 2025 Tue Jul 01 02:51:54 EDT 2025 Thu Apr 24 23:07:24 EDT 2025 Fri Feb 23 02:34:13 EST 2024 Sun Feb 23 10:19:37 EST 2025 Tue Aug 26 16:34:06 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Cambodia HEV |
| Language | English |
| License | Copyright © 2015 Elsevier B.V. All rights reserved. Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c525t-beec55f423f59f40cf4f73aeae3ba12ffcd3908dcf870211d6478bd4ae1cde03 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-9074-8850 0000-0002-6201-1261 |
| PMID | 26370310 |
| PQID | 1712777792 |
| PQPubID | 23479 |
| PageCount | 6 |
| ParticipantIDs | hal_primary_oai_HAL_hal_02332949v1 proquest_miscellaneous_1746891398 proquest_miscellaneous_1712777792 pubmed_primary_26370310 crossref_primary_10_1016_j_jcv_2015_07_304 crossref_citationtrail_10_1016_j_jcv_2015_07_304 elsevier_sciencedirect_doi_10_1016_j_jcv_2015_07_304 elsevier_clinicalkeyesjournals_1_s2_0_S1386653215006058 elsevier_clinicalkey_doi_10_1016_j_jcv_2015_07_304 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2015-10-01 |
| PublicationDateYYYYMMDD | 2015-10-01 |
| PublicationDate_xml | – month: 10 year: 2015 text: 2015-10-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | Journal of clinical virology |
| PublicationTitleAlternate | J Clin Virol |
| PublicationYear | 2015 |
| Publisher | Elsevier B.V Elsevier |
| Publisher_xml | – name: Elsevier B.V – name: Elsevier |
| References | Kamar, Dalton, Abravanel, Izopet (bib0005) 2014; 27 Tan, Tan, Ang, Chan, Chiew, Cutter (bib0040) 2013; 66 Mueller, Siv, Khim, Kim, Fleischmann, Ariey (bib0070) 2014; 9 Maylin, Stephan, Molina, Peraldi, Scieux, Nicand (bib0105) 2012; 53 Hogema, Molier, Slot, Zaaijer (bib0135) 2014; 54 Pineda, Cifuentes, Parra, Merchante, Perez-Navarro, Rivero-Juarez (bib0150) 2014; 28 Bouamra, Benali, Tissot-Dupont, Tamalet, Colson (bib0075) 2013; 51 Blanc, Sok, Laureillard, Borand, Rekacewicz, Nerrienet (bib0085) 2011; 365 Juhl, Baylis, Blumel, Gorg, Hennig (bib0140) 2014; 54 Kasper, Blair, Touch, Sokhal, Yasuda, Williams (bib0065) 2012; 86 Garson, Ferns, Grant, Ijaz, Nastouli, Szypulska (bib0095) 2012; 186 Dalton, Fellows, Stableforth, Joseph, Thurairajah, Warshow (bib0080) 2007; 26 Ijaz, Said, Boxall, Smit, Morgan, Tedder (bib0015) 2014; 209 Sedyaningsih-Mamahit, Larasati, Laras, Sidemen, Sukri, Sabaruddin (bib0035) 2002; 96 Faber, Wenzel, Jilg, Thamm, Hohle, Stark (bib0145) 2012; 18 Feldt, Sarfo, Zoufaly, Phillips, Burchard, van Lunzen (bib0090) 2013; 58 Baylis, Blumel, Mizusawa, Matsubayashi, Sakata, Okada (bib0130) 2013; 19 Gallian, Lhomme, Piquet, Saune, Abravanel, Assal (bib0110) 2014; 20 Rossi-Tamisier, Moal, Gerolami, Colson (bib0020) 2013; 56 Drobeniuc, Meng, Reuter, Greene-Montfort, Khudyakova, Dimitrova (bib0120) 2010; 51 Koot, Hogema, Koot, Molier, Zaaijer (bib0115) 2015; 62 Abravanel, Chapuy-Regaud, Lhomme, Miedouge, Peron, Alric (bib0125) 2013; 58 Abravanel, Chapuy-Regaud, Lhomme, Dubois, Peron, Alric (bib0030) 2013; 51 Hinjoy, Nelson, Gibbons, Jarman, Mongkolsirichaikul, Smithsuwan (bib0045) 2013; 60 Huang, Zhang, Jiang, Yan, Ai, Wang (bib0025) 2010; 5 Perez-Gracia, Suay, Mateos-Lindemann (bib0010) 2014; 22 Chhour, Ruble, Hong, Minn, Kdan, Sok (bib0055) 2002; 8 Xu, Wang, Schechterly, Ge, Shih, Xia (bib0100) 2013; 53 Ng, He, Saw, Lyles (bib0050) 2000; 55 Buchy, Monchy, An, Srey, Tri, Son (bib0060) 2004; 97 Huang (10.1016/j.jcv.2015.07.304_bib0025) 2010; 5 Blanc (10.1016/j.jcv.2015.07.304_bib0085) 2011; 365 Maylin (10.1016/j.jcv.2015.07.304_bib0105) 2012; 53 Tan (10.1016/j.jcv.2015.07.304_bib0040) 2013; 66 Rossi-Tamisier (10.1016/j.jcv.2015.07.304_bib0020) 2013; 56 Perez-Gracia (10.1016/j.jcv.2015.07.304_bib0010) 2014; 22 Ng (10.1016/j.jcv.2015.07.304_bib0050) 2000; 55 Kamar (10.1016/j.jcv.2015.07.304_bib0005) 2014; 27 Hogema (10.1016/j.jcv.2015.07.304_bib0135) 2014; 54 Bouamra (10.1016/j.jcv.2015.07.304_bib0075) 2013; 51 Hinjoy (10.1016/j.jcv.2015.07.304_bib0045) 2013; 60 Xu (10.1016/j.jcv.2015.07.304_bib0100) 2013; 53 Baylis (10.1016/j.jcv.2015.07.304_bib0130) 2013; 19 Kasper (10.1016/j.jcv.2015.07.304_bib0065) 2012; 86 Drobeniuc (10.1016/j.jcv.2015.07.304_bib0120) 2010; 51 Abravanel (10.1016/j.jcv.2015.07.304_bib0125) 2013; 58 Pineda (10.1016/j.jcv.2015.07.304_bib0150) 2014; 28 Sedyaningsih-Mamahit (10.1016/j.jcv.2015.07.304_bib0035) 2002; 96 Juhl (10.1016/j.jcv.2015.07.304_bib0140) 2014; 54 Koot (10.1016/j.jcv.2015.07.304_bib0115) 2015; 62 Feldt (10.1016/j.jcv.2015.07.304_bib0090) 2013; 58 Gallian (10.1016/j.jcv.2015.07.304_bib0110) 2014; 20 Faber (10.1016/j.jcv.2015.07.304_bib0145) 2012; 18 Buchy (10.1016/j.jcv.2015.07.304_bib0060) 2004; 97 Garson (10.1016/j.jcv.2015.07.304_bib0095) 2012; 186 Mueller (10.1016/j.jcv.2015.07.304_bib0070) 2014; 9 Chhour (10.1016/j.jcv.2015.07.304_bib0055) 2002; 8 Abravanel (10.1016/j.jcv.2015.07.304_bib0030) 2013; 51 Ijaz (10.1016/j.jcv.2015.07.304_bib0015) 2014; 209 Dalton (10.1016/j.jcv.2015.07.304_bib0080) 2007; 26 |
| References_xml | – volume: 26 start-page: 1429 year: 2007 end-page: 1435 ident: bib0080 article-title: The role of hepatitis E virus testing in drug-induced liver injury publication-title: Aliment. Pharmacol. Ther. – volume: 27 start-page: 116 year: 2014 end-page: 138 ident: bib0005 article-title: Hepatitis E virus infection publication-title: Clin. Microbiol. Rev. – volume: 58 start-page: 18 year: 2013 end-page: 23 ident: bib0090 article-title: Hepatitis E virus infections in HIV-infected patients in Ghana and Cameroon publication-title: J. Clin. Virol. – volume: 60 start-page: 555 year: 2013 end-page: 562 ident: bib0045 article-title: A cross-sectional study of hepatitis e virus infection in healthy people directly exposed and unexposed to pigs in a rural community in northern Thailand publication-title: Zoonoses Public Health – volume: 54 start-page: 49 year: 2014 end-page: 56 ident: bib0140 article-title: Seroprevalence and incidence of hepatitis E virus infection in German blood donors publication-title: Transfusion (Paris) – volume: 28 start-page: 1931 year: 2014 end-page: 1937 ident: bib0150 article-title: Incidence and natural history of hepatitis E virus coinfection among HIV-infected patients publication-title: AIDS – volume: 22 start-page: 40 year: 2014 end-page: 59 ident: bib0010 article-title: Hepatitis E an emerging disease publication-title: Infect. Genet. Evol. – volume: 54 start-page: 3092 year: 2014 end-page: 3096 ident: bib0135 article-title: Past and present of hepatitis E in the Netherlands publication-title: Transfusion (Paris) – volume: 5 start-page: e13560 year: 2010 ident: bib0025 article-title: Profile of acute infectious markers in sporadic hepatitis E publication-title: PLoS One – volume: 53 start-page: 2505 year: 2013 end-page: 2511 ident: bib0100 article-title: An assessment of hepatitis E virus (HEV) in US blood donors and recipients: no detectable HEV RNA in 1939 donors tested and no evidence for HEV transmission to 362 prospectively followed recipients publication-title: Transfusion (Paris) – volume: 9 start-page: e95868 year: 2014 ident: bib0070 article-title: Acute undifferentiated febrile illness in rural Cambodia: a 3-year prospective observational study publication-title: PLoS One – volume: 186 start-page: 157 year: 2012 end-page: 160 ident: bib0095 article-title: Minor groove binder modification of widely used TaqMan probe for hepatitis E virus reduces risk of false negative real-time PCR results publication-title: J. Virol. Methods – volume: 18 start-page: 1654 year: 2012 end-page: 1657 ident: bib0145 article-title: Hepatitis E virus seroprevalence among adults, Germany publication-title: Emerg. Infect. Dis. – volume: 55 start-page: 58 year: 2000 end-page: 64 ident: bib0050 article-title: A seroprevalence study of viral hepatitis E infection in human immunodeficiency virus type 1 infected subjects in Malaysia publication-title: Med. J. Malays. – volume: 66 start-page: 453 year: 2013 end-page: 459 ident: bib0040 article-title: Epidemiology of acute hepatitis E in Singapore publication-title: J. Infect. – volume: 51 start-page: 1052 year: 2013 end-page: 1056 ident: bib0075 article-title: Hepatitis B and E co-primary infections in an HIV-1-infected patient publication-title: J. Clin. Microbiol. – volume: 8 start-page: 485 year: 2002 end-page: 489 ident: bib0055 article-title: Hospital-based diagnosis of hemorrhagic fever, encephalitis, and hepatitis in Cambodian children publication-title: Emerg. Infect. Dis. – volume: 86 start-page: 246 year: 2012 end-page: 253 ident: bib0065 article-title: Infectious etiologies of acute febrile illness among patients seeking health care in south-central Cambodia publication-title: Am. J. Trop. Med. Hyg. – volume: 20 start-page: 1914 year: 2014 end-page: 1917 ident: bib0110 article-title: Hepatitis E virus infections in blood donors, France publication-title: Emerg. Infect. Dis. – volume: 62 start-page: 38 year: 2015 end-page: 40 ident: bib0115 article-title: Frequent hepatitis E in the Netherlands without traveling or immunosuppression publication-title: J. Clin. Virol. – volume: 56 start-page: 62 year: 2013 end-page: 64 ident: bib0020 article-title: Discrepancy between anti-hepatitis E virus immunoglobulin G prevalence assessed by two assays in kidney and liver transplant recipients publication-title: J. Clin. Virol. – volume: 51 start-page: e24 year: 2010 end-page: e27 ident: bib0120 article-title: Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances publication-title: Clin. Infect. Dis. – volume: 51 start-page: 1913 year: 2013 end-page: 1916 ident: bib0030 article-title: Performance of two commercial assays for detecting hepatitis E virus RNA in acute or chronic infections publication-title: J. Clin. Microbiol. – volume: 96 start-page: 398 year: 2002 end-page: 404 ident: bib0035 article-title: First documented outbreak of hepatitis E virus transmission in Java, Indonesia publication-title: Trans. R. Soc. Trop. Med. Hyg. – volume: 209 start-page: 1212 year: 2014 end-page: 1218 ident: bib0015 article-title: Indigenous hepatitis E in England and wales from 2003 to 2012: evidence of an emerging novel phylotype of viruses publication-title: J. Infect. Dis. – volume: 365 start-page: 1471 year: 2011 end-page: 1481 ident: bib0085 article-title: Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis publication-title: N. Engl. J. Med. – volume: 19 start-page: 729 year: 2013 end-page: 735 ident: bib0130 article-title: World Health Organization International Standard to harmonize assays for detection of hepatitis E virus RNA publication-title: Emerg. Infect. Dis. – volume: 53 start-page: 346 year: 2012 end-page: 349 ident: bib0105 article-title: Prevalence of antibodies and RNA genome of hepatitis E virus in a cohort of French immunocompromised publication-title: J. Clin. Virol. – volume: 97 start-page: 165 year: 2004 end-page: 171 ident: bib0060 article-title: Prevalence of hepatitis A–C and E virus markers among patients with elevated levels of alanine aminotransferase and aspartate aminotransferase in Phnom Penh (Cambodia) and Nha Trang (Central Vietnam) publication-title: Bull. Soc. Pathol. Exot. – volume: 58 start-page: 624 year: 2013 end-page: 628 ident: bib0125 article-title: Performance of anti-HEV assays for diagnosing acute hepatitis E in immunocompromised patients publication-title: J. Clin. Virol. – volume: 53 start-page: 2505 year: 2013 ident: 10.1016/j.jcv.2015.07.304_bib0100 article-title: An assessment of hepatitis E virus (HEV) in US blood donors and recipients: no detectable HEV RNA in 1939 donors tested and no evidence for HEV transmission to 362 prospectively followed recipients publication-title: Transfusion (Paris) doi: 10.1111/trf.12326 – volume: 66 start-page: 453 year: 2013 ident: 10.1016/j.jcv.2015.07.304_bib0040 article-title: Epidemiology of acute hepatitis E in Singapore publication-title: J. Infect. doi: 10.1016/j.jinf.2012.11.015 – volume: 186 start-page: 157 year: 2012 ident: 10.1016/j.jcv.2015.07.304_bib0095 article-title: Minor groove binder modification of widely used TaqMan probe for hepatitis E virus reduces risk of false negative real-time PCR results publication-title: J. Virol. Methods doi: 10.1016/j.jviromet.2012.07.027 – volume: 209 start-page: 1212 year: 2014 ident: 10.1016/j.jcv.2015.07.304_bib0015 article-title: Indigenous hepatitis E in England and wales from 2003 to 2012: evidence of an emerging novel phylotype of viruses publication-title: J. Infect. Dis. doi: 10.1093/infdis/jit652 – volume: 22 start-page: 40 year: 2014 ident: 10.1016/j.jcv.2015.07.304_bib0010 article-title: Hepatitis E an emerging disease publication-title: Infect. Genet. Evol. doi: 10.1016/j.meegid.2014.01.002 – volume: 5 start-page: e13560 year: 2010 ident: 10.1016/j.jcv.2015.07.304_bib0025 article-title: Profile of acute infectious markers in sporadic hepatitis E publication-title: PLoS One doi: 10.1371/journal.pone.0013560 – volume: 18 start-page: 1654 year: 2012 ident: 10.1016/j.jcv.2015.07.304_bib0145 article-title: Hepatitis E virus seroprevalence among adults, Germany publication-title: Emerg. Infect. Dis. doi: 10.3201/eid1810.111756 – volume: 51 start-page: e24 year: 2010 ident: 10.1016/j.jcv.2015.07.304_bib0120 article-title: Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances publication-title: Clin. Infect. Dis. doi: 10.1086/654801 – volume: 58 start-page: 624 year: 2013 ident: 10.1016/j.jcv.2015.07.304_bib0125 article-title: Performance of anti-HEV assays for diagnosing acute hepatitis E in immunocompromised patients publication-title: J. Clin. Virol. doi: 10.1016/j.jcv.2013.10.003 – volume: 8 start-page: 485 year: 2002 ident: 10.1016/j.jcv.2015.07.304_bib0055 article-title: Hospital-based diagnosis of hemorrhagic fever, encephalitis, and hepatitis in Cambodian children publication-title: Emerg. Infect. Dis. doi: 10.3201/eid0805.010236 – volume: 60 start-page: 555 year: 2013 ident: 10.1016/j.jcv.2015.07.304_bib0045 article-title: A cross-sectional study of hepatitis e virus infection in healthy people directly exposed and unexposed to pigs in a rural community in northern Thailand publication-title: Zoonoses Public Health doi: 10.1111/zph.12030 – volume: 58 start-page: 18 year: 2013 ident: 10.1016/j.jcv.2015.07.304_bib0090 article-title: Hepatitis E virus infections in HIV-infected patients in Ghana and Cameroon publication-title: J. Clin. Virol. doi: 10.1016/j.jcv.2013.05.004 – volume: 86 start-page: 246 year: 2012 ident: 10.1016/j.jcv.2015.07.304_bib0065 article-title: Infectious etiologies of acute febrile illness among patients seeking health care in south-central Cambodia publication-title: Am. J. Trop. Med. Hyg. doi: 10.4269/ajtmh.2012.11-0409 – volume: 51 start-page: 1913 year: 2013 ident: 10.1016/j.jcv.2015.07.304_bib0030 article-title: Performance of two commercial assays for detecting hepatitis E virus RNA in acute or chronic infections publication-title: J. Clin. Microbiol. doi: 10.1128/JCM.00661-13 – volume: 56 start-page: 62 year: 2013 ident: 10.1016/j.jcv.2015.07.304_bib0020 article-title: Discrepancy between anti-hepatitis E virus immunoglobulin G prevalence assessed by two assays in kidney and liver transplant recipients publication-title: J. Clin. Virol. doi: 10.1016/j.jcv.2012.09.010 – volume: 54 start-page: 49 year: 2014 ident: 10.1016/j.jcv.2015.07.304_bib0140 article-title: Seroprevalence and incidence of hepatitis E virus infection in German blood donors publication-title: Transfusion (Paris) doi: 10.1111/trf.12121 – volume: 9 start-page: e95868 year: 2014 ident: 10.1016/j.jcv.2015.07.304_bib0070 article-title: Acute undifferentiated febrile illness in rural Cambodia: a 3-year prospective observational study publication-title: PLoS One doi: 10.1371/journal.pone.0095868 – volume: 20 start-page: 1914 year: 2014 ident: 10.1016/j.jcv.2015.07.304_bib0110 article-title: Hepatitis E virus infections in blood donors, France publication-title: Emerg. Infect. Dis. doi: 10.3201/eid2011.140516 – volume: 19 start-page: 729 year: 2013 ident: 10.1016/j.jcv.2015.07.304_bib0130 article-title: World Health Organization International Standard to harmonize assays for detection of hepatitis E virus RNA publication-title: Emerg. Infect. Dis. doi: 10.3201/eid1905.121845 – volume: 97 start-page: 165 year: 2004 ident: 10.1016/j.jcv.2015.07.304_bib0060 article-title: Prevalence of hepatitis A–C and E virus markers among patients with elevated levels of alanine aminotransferase and aspartate aminotransferase in Phnom Penh (Cambodia) and Nha Trang (Central Vietnam) publication-title: Bull. Soc. Pathol. Exot. – volume: 54 start-page: 3092 year: 2014 ident: 10.1016/j.jcv.2015.07.304_bib0135 article-title: Past and present of hepatitis E in the Netherlands publication-title: Transfusion (Paris) doi: 10.1111/trf.12733 – volume: 53 start-page: 346 year: 2012 ident: 10.1016/j.jcv.2015.07.304_bib0105 article-title: Prevalence of antibodies and RNA genome of hepatitis E virus in a cohort of French immunocompromised publication-title: J. Clin. Virol. doi: 10.1016/j.jcv.2012.01.001 – volume: 62 start-page: 38 year: 2015 ident: 10.1016/j.jcv.2015.07.304_bib0115 article-title: Frequent hepatitis E in the Netherlands without traveling or immunosuppression publication-title: J. Clin. Virol. doi: 10.1016/j.jcv.2014.11.020 – volume: 27 start-page: 116 year: 2014 ident: 10.1016/j.jcv.2015.07.304_bib0005 article-title: Hepatitis E virus infection publication-title: Clin. Microbiol. Rev. doi: 10.1128/CMR.00057-13 – volume: 55 start-page: 58 year: 2000 ident: 10.1016/j.jcv.2015.07.304_bib0050 article-title: A seroprevalence study of viral hepatitis E infection in human immunodeficiency virus type 1 infected subjects in Malaysia publication-title: Med. J. Malays. – volume: 51 start-page: 1052 year: 2013 ident: 10.1016/j.jcv.2015.07.304_bib0075 article-title: Hepatitis B and E co-primary infections in an HIV-1-infected patient publication-title: J. Clin. Microbiol. doi: 10.1128/JCM.02630-12 – volume: 96 start-page: 398 year: 2002 ident: 10.1016/j.jcv.2015.07.304_bib0035 article-title: First documented outbreak of hepatitis E virus transmission in Java, Indonesia publication-title: Trans. R. Soc. Trop. Med. Hyg. doi: 10.1016/S0035-9203(02)90373-1 – volume: 28 start-page: 1931 year: 2014 ident: 10.1016/j.jcv.2015.07.304_bib0150 article-title: Incidence and natural history of hepatitis E virus coinfection among HIV-infected patients publication-title: AIDS doi: 10.1097/QAD.0000000000000378 – volume: 26 start-page: 1429 year: 2007 ident: 10.1016/j.jcv.2015.07.304_bib0080 article-title: The role of hepatitis E virus testing in drug-induced liver injury publication-title: Aliment. Pharmacol. Ther. doi: 10.1111/j.1365-2036.2007.03504.x – volume: 365 start-page: 1471 year: 2011 ident: 10.1016/j.jcv.2015.07.304_bib0085 article-title: Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1013911 |
| SSID | ssj0015347 |
| Score | 2.2093582 |
| Snippet | •HEV infection was retrospectively assessed in 825 Cambodian subjects.•We found an overall anti-HEV IgM prevalence rate of 1.1%.•No subject tested positive for... Highlights • HEV infection was retrospectively assessed in 825 Cambodian subjects. • We found an overall anti-HEV IgM prevalence rate of 1.1%. • No subject... In Cambodia, previous studies conducted on hepatitis E virus (HEV) infection are scant, sometimes old, and showed inconsistent results. Moreover, there is no... Background In Cambodia, previous studies conducted on hepatitis E virus (HEV) infection are scant, sometimes old, and showed inconsistent results. Moreover,... BACKGROUND: In Cambodia, previous studies conducted on hepatitis E virus (HEV) infection are scant, sometimes old, and showed inconsistent results. Moreover,... |
| SourceID | hal proquest pubmed crossref elsevier |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 22 |
| SubjectTerms | Adolescent Adult Aged Allergy and Immunology Cambodia Cambodia - epidemiology Child Child, Preschool Enzymes - blood Female Hepatitis Antibodies - blood Hepatitis E - epidemiology Hepatitis E - pathology Hepatitis E virus Hepatitis E virus - genetics Hepatitis E virus - immunology Hepatitis E virus - isolation & purification Hepeviridae HEV HIV Infections - complications Human health and pathology Human immunodeficiency virus Human immunodeficiency virus 1 Humans Immunoglobulin G - blood Immunoglobulin M - blood Infant Infant, Newborn Infectious Disease Infectious diseases Lentivirus Life Sciences Liver - enzymology Liver Function Tests Male Middle Aged Prevalence Retrospective Studies Retroviridae RNA, Viral - blood Young Adult |
| Title | Low frequency of acute hepatitis E virus (HEV) infections but high past HEV exposure in subjects from Cambodia with mild liver enzyme elevations, unexplained fever or immunodeficiency due to HIV-1 infection |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1386653215006058 https://www.clinicalkey.es/playcontent/1-s2.0-S1386653215006058 https://dx.doi.org/10.1016/j.jcv.2015.07.304 https://www.ncbi.nlm.nih.gov/pubmed/26370310 https://www.proquest.com/docview/1712777792 https://www.proquest.com/docview/1746891398 https://hal.science/hal-02332949 |
| Volume | 71 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6VIiQuiDfhUQ2IAyBMbO_ajo9RlcqF0gul6m1l70N1ldpRbAfCgZ_Ib2LGjyBECRK5xZm1J9nZmcnu980w9jLSaBRcoPEShEpMBHfoNMtxjYgnVmHQyIgo_PE4TD6L92fB2Q7bH7gwBKvsfX_n01tv3V8Z97_meJHn408ep1ptHGMWFRUJiPArRERW_u77BuaBC7ptMkbCDkkPJ5stxutCrQjdFVD9Tt73arsiNl07J5Dk3zLQNhId3Ga3-hQSpp2Wd9iOKe6yG11TyfU99uOo_AJ22UGk11BaSFVTGzg3BJ6u8wpmsMqXTQWvktnpaxjgWEUFWVMD1S-GRVrVgJ-C-booaQ8RpaBqMtq0qYAoKUBkrxKNC2gnFy7zuYY5YTzAFN_WlwaIt97tBr6FpsD7zFNMaDVYQ0LlEnJippTaUAmLVlPdGKhLSA5PHe-XVvfZycHsZD9x-q4Njgr8oHYyY1QQWEzTbBBb4SorbMRTkxqepZ5vrdI8didaWXQV-PdTE9s10yI1ntLG5Q_YblEW5hEDYzPMxyI14SgTijRNdaRN7Cs_xNvEwYi5w3RJ1Vc0p8YaczlA1y4kzrCkGZZuJHGGR-zNZsiiK-exTdgfbEAOPFX0rBKDzbZB0VWDTNX7hkp6svKlK_-w3xETm5G_LYF_PfAFmufm21C58GR6JOka5mPcj0W88kbs-WC9Ev0HHQqlhSkb1Cby_Ahfsb9NRoR0nB2jjg870988zw85tUBwH_-f9k_YTXrXwSOfst162ZhnmObV2V67jvfY9enhh-T4Jz4CUog |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF61RQguiDfhOSAOgGpie9dxfKyqVC6kvVCq3lb2PlRXqR3FdiAc-In8Jmb8CEKUIOHjenY99s7OjHe_mWHsdahRKLhA4SUIlRgL7tBpluMaEY2tQqORUqDw0fEo_iw-nAVnW2y_j4UhWGWn-1ud3mjrrmXYfc3hPMuGnzxOudo42ixKKhKMt9k1gcuXyhi8_77GeeCKbqqMEbVD5P3RZgPyulBLgncFlMCTd8XarjBO2-eEkvybC9qYooPb7FbnQ8Jey-YdtmXyu-x6W1VydY_9mBZfwC5ajPQKCguJqisD54bQ01VWwgSW2aIu4U08OX0LPR4rLyGtK6AExjBPygrwLpiv84I2EZEKyjqlXZsSKCYFKNqrQOkC2sqFy2ymYUYgDzD5t9WlAQpcb7cDd6HOcZxZgh6tBmuIqFhARqEphTaUw6LhVNcGqgLiw1PH-8XVfXZyMDnZj52ubIOjAj-onNQYFQQW_TQbRFa4ygob8sQkhqeJ51urNI_csVYWdQX-f2oKd021SIyntHH5A7aTF7l5xMDYFB2yUI050oxEkiQ61CbylT_CYaJgwNx-uqTqUppTZY2Z7LFrFxJnWNIMSzeUOMMD9m7dZd7m89hE7PcyIPtAVVStEq3Npk7hVZ1M2SmHUnqy9KUr_xDgARPrnr-tgX898BWK5_ptKF94vDeV1IYOGfcjES29AXvZS69EBUKnQkluihq5CT0_xCvyN9GIEZ1nR8jjw1b018_zR5xqILiP_4_7F-xGfHI0ldPD449P2E2602Iln7KdalGbZ-jzVenzZk3_BIGaVBY |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Low+frequency+of+acute+hepatitis+E+virus+%28HEV%29+infections+but+high+past+HEV+exposure+in+subjects+from+Cambodia+with+mild+liver+enzyme+elevations%2C+unexplained+fever+or+immunodeficiency+due+to+HIV-1+infection&rft.jtitle=Journal+of+clinical+virology&rft.au=Nouhin%2C+Janin&rft.au=Barennes%2C+Hubert&rft.au=Madec%2C+Yoann&rft.au=Prak%2C+Sophearot&rft.date=2015-10-01&rft.issn=1386-6532&rft.volume=71&rft.spage=22&rft.epage=27&rft_id=info:doi/10.1016%2Fj.jcv.2015.07.304&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_jcv_2015_07_304 |
| thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F13866532%2FS1386653215X00102%2Fcov150h.gif |